Summarily, this study revealed circRNA profile of NSCLC for the first time and provided the evidence of plasma circFARSA as a potential noninvasive biomarker for this malignancy.
A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer.